Home

Alterity Therapeutics (ASX: ATH) - Webinar Presentation

PUBLISHED

2023-03-13

Content

Dr David Stamler, CEO - Alterity Therapeutics is a clinical stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases.